The global Dental Consumables Market is expected to be worth US$ 42.0 billion in 2023, rising at a 5.6% CAGR to US$ 72.6 billion by the end of 2033. According to a recent Future Market Insights study, restorative products will account for approximately 29.6% of the global dental consumables market in 2022. Excessive use of …
Category Archives: Healthcare Trends
Biodefense Market: Fortifying Protection, Expected to Achieve a US$ 32.99 Billion Size by 2033
In 2023, the global Biodefense Market was valued at US$ 16.31 billion, with a projected increase to US$ 32.99 billion by 2033. This market is expected to grow at a CAGR of 7.3% during the analysis period. Companies will have more opportunities to expand their operations and enter new markets as demand for vaccines, drugs, …
Medical Disposables Market: Pioneering Disposable Health Solutions on the Path to a US$ 326.4 Billion Horizon by 2033
The Medical Disposables Market revenues were estimated at US$ 153.5 Billion in 2022 and is anticipated to grow at a CAGR of 7.1% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 326.4 Billion. Bandages and Wound Dressings commanded the largest …
Gastro-retentive Drug Delivery Systems Market: Embracing Persistence Toward a US$ 24.8 Billion Milestone by 2033
According to a recently published Future Market Insights report, the Gastro-retentive Drug Delivery Systems Market is expected to grow at a CAGR of 10.1% between 2023 and 2033, with revenues estimated at US$ 13.3 billion in 2022. The market is expected to reach US$ 24.8 billion by the end of 2033. Large drug firms’ investments …
Serum Separation Gels Market Expected to Surge at 5% CAGR, Aiming for US$ 12.39 Billion by 2032 | Reveals Future Market Insights’ Study
The serum separation gels market is expected to grow at a 5% CAGR during the forecast period, from US$ 7.61 billion in 2022 to US$ 12.39 billion by 2032. The Global Serum Separation Gels market study provides critical information related to the global, regional and top players including Serum Separation Gels market share analysis, winning strategies, recent developments, and …
Pancreatic Stone Protein Testing Market to Surge at 1.8% CAGR, Targeting US$ 3.59 Billion by 2032 | FMI Reveals
During the forecast period, the pancreatic stone protein testing market is expected to grow at a rapid 1.8% CAGR. The pancreatic stone protein testing market is currently valued at US$ 3 billion in 2022, with a projected value of US$ 3.59 billion by 2032. Different pancreatic secretory proteins have been identified in the last decade. That is …
Peptide Receptor Radionuclide Therapy (PRRT) Market Report: Unveiling a 7.2% CAGR Ascent Toward US$ 1,106.50 Million by 2032 | FMI
During the forecast period, the peptide receptor radionuclide therapy (prrt) market is expected to grow at a strong CAGR of 7.2%. The market is currently worth US$ 552.08 million in 2022 and is expected to grow by US$ 1,106.50 million by 2032. This Peptide Receptor Radionuclide Therapy market study offers a comprehensive analysis of the business models, key …
Next Generation Infusion Pump Sector’s Robust Growth at 4.8% CAGR, Aiming for US$ 8509 Million by 2032 | FMI Analysis
The global next generation infusion pump market is expected to reach US$ 5059.7 million in 2022 and US$ 8509 million by 2032, with a CAGR of 4.8% during the forecast period (2022-2032). Next Generation Infusion Pumps are a combination of intuitive user interface, simplicity, state of the art information technology. They are inclined with an advanced pumping …
Insightful Analysis: New Born Eye Imaging Systems Market to Grow at 5.7% CAGR, Reaching US$ 374.3 Million by 2032 | FMI
It is anticipated that the new born eye imaging systems market will reach US$ 374.3 million by 2032, up from US$ 202.7 million in 2022, growing at a CAGR of 5.7% during the projection period. Eye is the most complex sensory organ of the body, eye is like a camera of higher resolution for capturing the image, …
A Comprehensive Study: Myelodysplastic Syndrome Treatment Market’s Path to US$ 5,614.1 Million by 2032 | FMI
The global myelodysplastic syndrome treatment market is poised to register a 5.9% CAGR, capturing a revenue share of US$ 2,990.8 million in 2022, to reach US$ 5,614.1 million by 2032. Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow are damaged. This damage leads to low numbers of one or more type of …